ARCH Venture Partners VIII, LLC 3/A
3/A · Sienna Biopharmaceuticals, Inc. · Filed Jul 31, 2017
Insider Transaction Report
Form 3/AAmended
ARCH Venture Partners VIII, LLC
10% Owner
Holdings
- (indirect: See Footnote)
Series A-3 Preferred Stock
→ Common Stock (2,538,641 underlying)
Footnotes (1)
- [F1]This amendment is filed solely to include a copy of a power of attorney form which was inadvertently omitted from the original filing. One line in the original filing has been restated without restating the original footnotes in order to gain access to the filing system. None of the information in the body of the original filing is incorrect or being amended via this amendment.